Medical policy
View NCDs
CMS develops NCDs to describe circumstances for Medicare coverage nationwide for an item or service. NCDs generally outline the conditions for which an item or service is covered (or not covered)…
View NCDs
CMS develops NCDs to describe circumstances for Medicare coverage nationwide for an item or service. NCDs generally outline the conditions for which an item or service is covered (or not covered)…
Independent diagnostic testing facility (IDTF) quick reference
IDTFs are required to report the exact CPT/HCPCS codes and procedures they intend to perform when enrolling with the CMS-855B form.
Contractor advisory committee (CAC) meeting minutes
View CAC meeting minutes from our meeting on February 19, 2026, on the use of urine-based biomarkers in patients with microhematuria.
Contractor advisory committee (CAC) meeting minutes
View CAC meeting minutes from our meeting on February 19, 2026, on the use of urine-based biomarkers in patients with microhematuria.
Pre-market approval (PMA), PMA post-approval studies, pre-market notification (PMN) 510(k), and 510(k) post-approval extension studies
Read about pre-market approval (PMA), PMA post-approval studies, pre-market notification (PMN) 510(k), and 510(k) post-approval extension studies guidelines related only to percutaneous transluminal…
Pre-market approval (PMA), PMA post-approval studies, pre-market notification (PMN) 510(k), and 510(k) post-approval extension studies
Read about pre-market approval (PMA), PMA post-approval studies, pre-market notification (PMN) 510(k), and 510(k) post-approval extension studies guidelines related only to percutaneous transluminal…
‘Reasonable and necessary’ guidelines
View these guidelines regarding what it means for a service to be "reasonable and necessary."